Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Baxter
Medtronic
Johnson and Johnson
Moodys

Last Updated: January 27, 2023

Details for Patent: 6,545,040


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 6,545,040
Title: Method of lowering the blood pressure
Abstract:A method of potentiating the effects of blood pressure reducing agents in warm-blooded animals, said method comprising administering to said warm-blooded animals of an effective amount of a blood pressure reducing agent and a 2,2'-iminobisethanol derivative.
Inventor(s): Xhonneux; Raymond Mathieu (Vlimmeren, BE), Van Lommen; Guy Rosalia Eugene (Berlaar, BE)
Assignee: Janssen Pharmaceutica N.V. (BE)
Application Number:07/825,488
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,545,040
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 6,545,040

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Johnson and Johnson
Medtronic
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.